BMJ  2005;330 (7 May), doi:10.1136/bmj.330.7499.0-a

For newly diagnosed ischaemic heart disease give a statin, aspirin, and {beta} blocker

Combinations of statins, aspirins, and {beta} blockers are associated with the greatest reduction in all cause mortality in patients with a first diagnosis of ischaemic heart disease. In a case-control analysis including 13 029 patients nested within an open prospective cohort study with 1.18 million patients, Hippisley-Cox and Coupland (p 1059) compared odds ratios for risk of death in patients with heart disease who were on different treatment regimens. The addition of an angiotensin converting enzyme inhibitor conferred no additional benefit despite adjusting the analyses for the presence of congestive heart failure.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis
Julia Hippisley-Cox and Carol Coupland
BMJ 2005 330: 1059-1063. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Implementing the evidence- SaM
Israel Rabinowitz
bmj.com, 20 Jun 2005 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ